Vestmark Advisory Solutions, Inc. Sarepta Therapeutics, Inc. Transaction History

Vestmark Advisory Solutions, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$117.53 - $155.99 $3,525 - $4,679	-30 Reduced 1.04%	2,858 $393,000
Q4 2022 Jan 20, 2023	SELL	$100.86 - $132.13 $54,968 - $72,010	-545 Reduced 15.88%	2,888 $0
Q3 2022 Nov 03, 2022	SELL	$75.71 - $119.24 $104,025 - $163,835	-1,374 Reduced 28.58%	3,433 $379,000
Q2 2022 Aug 04, 2022	SELL	$62.69 - $88.44 $72,908 - $102,855	-1,163 Reduced 19.48%	4,807 $360,000
Q1 2022 Apr 27, 2022	SELL	$63.15 - $90.42 $61,192 - $87,616	-969 Reduced 13.96%	5,970 $466,000
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $38,064 - $53,360	577 Added 9.07%	6,939 $642,000
Q2 2021 Aug 09, 2021	BUY	$69.38 - $86.75 $27,058 - $33,832	390 Added 6.53%	6,362 $495,000
Q1 2021 May 10, 2021	BUY	$72.25 - $168.95 $431,477 - $1.01 Million	5,972 New	5,972 $445,000

530

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.